Amgen Delivers Mixed Data For Rocatinlimab In Atopic Dermatitis, Uplizna In Myasthenia Gravis

Four Of Seven More AD Trials To Read Out Over Next Year

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.